SCHEMBL248053

SCHEMBL248053

Cc1ccc(NNC(=O)C(O)(c2ccccc2)c2ccccc2)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.51
GAA P10253 8/20 0.51
ALDH1A1 P00352 8/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
AGTR1 P30556 3/20 0.51
HTT P42858 3/20 0.51
POLB P06746 3/20 0.51
NPSR1 Q6W5P4 2/20 0.51
CDC7 O00311 2/20 0.49
PLK4 O00444 2/20 0.49
AURKA O14965 2/20 0.49
PDPK1 O15530 2/20 0.49
DAPK3 O43293 2/20 0.49
DYRK3 O43781 2/20 0.49
PRKD3 O94806 2/20 0.49
MAP4K4 O95819 2/20 0.49
PIM1 P11309 2/20 0.49
PHKG2 P15735 2/20 0.49
CDK2 P24941 2/20 0.49
MARK3 P27448 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15540565 0.79 MAPT (0.65) MAPTGAAALDH1A1SMN1; SMN2AGTR1
SCHEMBL246611 0.74 ALDH1A1 (0.47) MAPTGAAALDH1A1SMN1; SMN2AGTR1
SCHEMBL14108123 0.74 FAAH (0.57) MAPTGAAALDH1A1SMN1; SMN2AGTR1
SCHEMBL246915 0.72 ALDH1A1 (0.54) MAPTGAAALDH1A1SMN1; SMN2AGTR1
SCHEMBL15559125 0.70 MAPT (0.54) MAPTGAAALDH1A1SMN1; SMN2AGTR1
SCHEMBL1083471 0.69 SMN1; SMN2 (0.65) MAPTGAAALDH1A1SMN1; SMN2HTT
SCHEMBL4111390 0.69 SMN1; SMN2 (0.75) MAPTALDH1A1SMN1; SMN2HTTPOLB
SCHEMBL7748140 0.68 NPC1 (0.73) MAPTGAAALDH1A1SMN1; SMN2AGTR1
Fluoride SCHEMBL11790867 0.68 SMN1; SMN2 (0.63) MAPTGAAALDH1A1SMN1; SMN2HTT
Hydrochloric Acid SCHEMBL11158946 0.68 SMN1; SMN2 (0.63) MAPTALDH1A1SMN1; SMN2HTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012000036-A1 TREATMENT OF ABNORMALITIES OF GLUCOSE METABOLISM WITH AN ANTAGONIST OF INHIBITOR OF DIFFERENTIATION 1 GARVAN INSTITUTE OF MEDICAL RESEARCH (AU) 2012-01-05 WO disclosed